THEMISMED — Themis Medicare Cashflow Statement
0.000.00%
- IN₹11.49bn
- IN₹12.13bn
- IN₹4.06bn
- 95
- 16
- 15
- 36
Annual cashflow statement for Themis Medicare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 413 | 953 | 725 | 534 | 397 |
Depreciation | |||||
Non-Cash Items | -8.83 | -97.2 | -105 | -137 | 9.65 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 79.8 | -606 | -565 | -299 | -159 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 570 | 344 | 161 | 221 | 347 |
Capital Expenditures | -180 | -206 | -287 | -184 | -154 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 23.9 | 50.4 | 47.9 | 24.7 | 32.5 |
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -157 | -156 | -240 | -159 | -122 |
Financing Cash Flow Items | -110 | -65.4 | -79.9 | -76.3 | -84.9 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -256 | -175 | 1.36 | -87.7 | -259 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 157 | 12.6 | -77.3 | -26.2 | -33.6 |